2nd Next Generation RNA Therapeutics Summit
Bringing Next Generation RNA Therapies to Patients Faster
Newsletters and Deep Dive digital magazine
Bringing Next Generation RNA Therapies to Patients Faster
Outside of the main headlines, our new Trends & Insights report looks at the wider breadth of life sciences industry news.
AC Immune's active immunotherapy study backs up the alpha-synuclein hypothesis in Parkinson's disease, after disappointments in earlier trials.
As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
Daniel Kohlstaedt, managing director of PurpleLeaf Strategy, with more than 18 years of experience in pharma, talks about his journey through the industry.
In a new white paper from Lumanity, explore why the most powerful AI will always be human-directed.
For Rare Disease Day, in an AOP Health-sponsored podcast Melissa Fellner, VP of Global Therapeutic Areas, Commercial Operations, discussed their work.
A new industry report uncovers the scope of a long-ignored problem in clinical trial operations.
The Pharmaceutical Manufacturing & Packaging Congress is an exclusive annual event that fosters networking and knowledge-sharing among professionals
The Summit is the leading European industry-focused forum dedicated to accelerating the development of messenger RNA (mRNA) medicines
Get in-depth news, opinions, and features on pharma and healthcare sent straight to your inbox